Rafferty Asset Management, LLC Adverum Biotechnologies, Inc. Transaction History

Rafferty Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.81 - $1.34 $20,311 - $33,601	25,076 Added 55.88%	69,954 $84,000
Q1 2022 May 13, 2022	SELL	$1.23 - $1.95 $5,201 - $8,246	-4,229 Reduced 8.61%	44,878 $59,000
Q4 2021 Feb 10, 2022	BUY	$1.74 - $2.4 $27,679 - $38,179	15,908 Added 47.92%	49,107 $86,000
Q3 2021 Nov 10, 2021	SELL	$2.08 - $3.6 $862,338 - $1.49 Million	-414,586 Reduced 92.59%	33,199 $72,000
Q2 2021 Aug 10, 2021	SELL	$3.36 - $10.56 $434,202 - $1.36 Million	-129,227 Reduced 22.4%	447,785 $1.57 Million
Q1 2021 May 10, 2021	BUY	$9.26 - $14.36 $4.55 Million - $7.05 Million	491,187 Added 572.31%	577,012 $5.69 Million
Q4 2020 Feb 10, 2021	SELL	$9.84 - $14.26 $733,296 - $1.06 Million	-74,522 Reduced 46.48%	85,825 $930,000
Q3 2020 Nov 13, 2020	BUY	$10.3 - $21.64 $1.29 Million - $2.72 Million	125,726 Added 363.15%	160,347 $1.65 Million
Q2 2020 Aug 07, 2020	BUY	$8.53 - $25.64 $187,549 - $563,746	21,987 Added 174.03%	34,621 $723,000
Q1 2020 May 15, 2020	SELL	$7.98 - $16.32 $755,362 - $1.54 Million	-94,657 Reduced 88.22%	12,634 $123,000
Q4 2019 Feb 10, 2020	SELL	$5.12 - $12.22 $1.37 Million - $3.28 Million	-268,406 Reduced 71.44%	107,291 $1.24 Million
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $1.75 Million - $5.29 Million	333,121 Added 782.41%	375,697 $2.05 Million
Q2 2019 Aug 09, 2019	BUY	$5.1 - $11.89 $217,137 - $506,228	42,576 New	42,576 $506,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.